{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T21:47:13Z","timestamp":1778276833723,"version":"3.51.4"},"reference-count":78,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ackdjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Chronic Kidney Disease"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1053\/j.ackd.2020.01.002","type":"journal-article","created":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T03:09:00Z","timestamp":1592190540000},"page":"155-164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Complement-Mediated Disorders in Pregnancy"],"prefix":"10.1053","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8657-0909","authenticated-orcid":false,"given":"Kana","family":"Amari Chinchilla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madhusudan","family":"Vijayan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruna","family":"Taveras Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Belinda","family":"Jim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1053\/j.ackd.2020.01.002_bib1","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nri2620","article-title":"Complement regulators and inhibitory proteins","volume":"9","author":"Zipfel","year":"2009","journal-title":"Nat Rev Immunol"},{"issue":"C","key":"10.1053\/j.ackd.2020.01.002_bib2","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0065-2776(08)04004-2","article-title":"The amplification loop of the complement pathways","volume":"104","author":"Lachmann","year":"2009","journal-title":"Adv Immunol"},{"issue":"8","key":"10.1053\/j.ackd.2020.01.002_bib3","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1172\/JCI16651","article-title":"Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome","volume":"111","author":"Manuelian","year":"2003","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1053\/j.ackd.2020.01.002_bib4","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1182\/blood-2005-10-007252","article-title":"Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome","volume":"108","author":"Caprioli","year":"2006","journal-title":"Blood"},{"issue":"13","key":"10.1053\/j.ackd.2020.01.002_bib5","doi-asserted-by":"crossref","first-page":"4948","DOI":"10.1182\/blood-2008-01-133702","article-title":"Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome","volume":"112","author":"Fr\u00e9meaux-Bacchi","year":"2008","journal-title":"Blood"},{"issue":"5","key":"10.1053\/j.ackd.2020.01.002_bib6","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/j.1538-7836.2005.01267.x","article-title":"Soluble thrombomodulin activity and soluble thrombomodulin antigen in plasma","volume":"3","author":"Ohlin","year":"2005","journal-title":"J Thromb Haemost"},{"issue":"4","key":"10.1053\/j.ackd.2020.01.002_bib7","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1056\/NEJMoa0810739","article-title":"Thrombomodulin mutations in atypical hemolytic-uremic syndrome","volume":"361","author":"Delvaeye","year":"2009","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1053\/j.ackd.2020.01.002_bib8","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1681\/ASN.2012090884","article-title":"Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype","volume":"24","author":"Bresin","year":"2013","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1053\/j.ackd.2020.01.002_bib9","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s11906-018-0836-4","article-title":"The complement alternative pathway and preeclampsia","volume":"20","author":"Alrahmani","year":"2018","journal-title":"Curr Hypertens Rep"},{"issue":"1","key":"10.1053\/j.ackd.2020.01.002_bib10","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1365-2141.2009.07916.x","article-title":"Clinical practice guidelines for the management of atypical haemolytic uraemic syndrome in the United Kingdom","volume":"148","author":"Taylor","year":"2010","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1053\/j.ackd.2020.01.002_bib11","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.transci.2016.04.009","article-title":"Pregnancy-related thrombotic microangiopathies: clues from complement biology","volume":"54","author":"Fakhouri","year":"2016","journal-title":"Transfus Apher Sci"},{"issue":"3","key":"10.1053\/j.ackd.2020.01.002_bib12","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1365-2141.2012.09167.x","article-title":"Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies","volume":"158","author":"Scully","year":"2012","journal-title":"Br J Haematol"},{"issue":"21","key":"10.1053\/j.ackd.2020.01.002_bib13","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1182\/blood-2016-11-709865","article-title":"HUS and atypical HUS","volume":"129","author":"Jokiranta","year":"2017","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.ackd.2020.01.002_bib14","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1146\/annurev.med.59.060106.185110","article-title":"Complement regulatory genes and hemolytic uremic syndromes","volume":"59","author":"Kavanagh","year":"2008","journal-title":"Annu Rev Med"},{"key":"10.1053\/j.ackd.2020.01.002_bib15","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.kint.2016.10.005","article-title":"Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a \u201cKidney Disease: Improving Global Outcomes\u201d (KDIGO) controversies conference","volume":"91","author":"Goodship","year":"2017","journal-title":"Kidney Int"},{"key":"10.1053\/j.ackd.2020.01.002_bib16","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1056\/NEJMoa1208981","article-title":"Terminal complement inhibitor eculizumab in atypical hemolytic\u2013uremic syndrome","volume":"368","author":"Legendre","year":"2019","journal-title":"NEJM"},{"issue":"5","key":"10.1053\/j.ackd.2020.01.002_bib17","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1681\/ASN.2009070706","article-title":"Pregnancy-associated hemolytic uremic syndrome revisited in the era of complement gene mutations","volume":"21","author":"Fakhouri","year":"2010","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.ackd.2020.01.002_bib18","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1258\/om.2011.100059","article-title":"Pregnancy-associated atypical haemolytic uraemic syndrome in the postpartum period: a case report and review of the literature","volume":"4","author":"Egbor","year":"2011","journal-title":"Obstet Med"},{"issue":"8","key":"10.1053\/j.ackd.2020.01.002_bib19","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.2215\/CJN.00280117","article-title":"Article hemolytic uremic syndrome in pregnancy and postpartum","volume":"12","author":"Bruel","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"10.1053\/j.ackd.2020.01.002_bib20","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/ki.2014.423","article-title":"Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2-year extensions of phase 2 studies","volume":"87","author":"Licht","year":"2015","journal-title":"Kidney Int"},{"issue":"3","key":"10.1053\/j.ackd.2020.01.002_bib21","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3390\/jcm8030407","article-title":"The extended use of eculizumab in pregnancy and complement activation\u2013associated diseases affecting maternal, fetal and neonatal kidneys-the future is now?","volume":"8","author":"Stefanovic","year":"2019","journal-title":"J Clin Med"},{"issue":"6","key":"10.1053\/j.ackd.2020.01.002_bib22","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1002\/eji.1830220635","article-title":"Complement regulatory proteins at the feto-maternal interface during human placental development: distribution of CD59 by comparison with membrane cofactor protein(CD46) and decay accelerating factor (CD55)","volume":"22","author":"Holmes","year":"1992","journal-title":"Eur J Immunol"},{"key":"10.1053\/j.ackd.2020.01.002_bib23","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.kint.2017.06.022","article-title":"A retrospective study of pregnancy-associated atypical hemolytic uremic syndrome","volume":"93","author":"Huerta","year":"2018","journal-title":"Kidney Int"},{"issue":"11","key":"10.1053\/j.ackd.2020.01.002_bib24","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nrneph.2012.214","article-title":"Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies","volume":"8","author":"Zuber","year":"2012","journal-title":"Nat Rev Nephrol"},{"issue":"10","key":"10.1053\/j.ackd.2020.01.002_bib25","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.2215\/CJN.02210310","article-title":"Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype","volume":"5","author":"Noris","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.ackd.2020.01.002_bib26","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.transci.2018.03.005","article-title":"Efficacy of eculizumab in severe ADAMTS13-deficient thrombotic thrombocytopenic purpura (TTP) refractory to standard therapies","volume":"57","author":"Vigna","year":"2018","journal-title":"Transfus Apher Sci"},{"issue":"2","key":"10.1053\/j.ackd.2020.01.002_bib27","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.placenta.2012.11.014","article-title":"Eculizumab for the treatment of preeclampsia\/HELLP syndrome","volume":"34","author":"Burwick","year":"2013","journal-title":"Placenta"},{"issue":"9","key":"10.1053\/j.ackd.2020.01.002_bib28","doi-asserted-by":"crossref","first-page":"e228709","DOI":"10.1136\/bcr-2018-228709","article-title":"Eculizumab, a novel potential treatment for acute kidney injury associated with preeclampsia\/HELLP syndrome","volume":"12","author":"Elabd","year":"2019","journal-title":"BMJ Case Rep"},{"issue":"2","key":"10.1053\/j.ackd.2020.01.002_bib29","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/ckj\/sfs185","article-title":"Post-partum atypical haemolytic-uraemic syndrome treated with eculizumab: terminal complement activity assessment in clinical practice","volume":"6","author":"Delmas","year":"2013","journal-title":"Clin Kidney J"},{"issue":"12","key":"10.1053\/j.ackd.2020.01.002_bib30","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1093\/ndt\/gfw314","article-title":"Atypical haemolytic uraemic syndrome and pregnancy: outcome with ongoing eculizumab","volume":"31","author":"Servais","year":"2016","journal-title":"Nephrol Dial Transpl"},{"issue":"1","key":"10.1053\/j.ackd.2020.01.002_bib31","doi-asserted-by":"crossref","first-page":"e226571","DOI":"10.1136\/bcr-2018-226571","article-title":"Recurrent case of pregnancy-induced atypical haemolytic uremic syndrome (P-aHUS)","volume":"12","author":"Kumar","year":"2019","journal-title":"BMJ Case Rep"},{"issue":"11","key":"10.1053\/j.ackd.2020.01.002_bib32","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/j.ekir.2019.08.020","article-title":"Use of eculizumab during pregnancy in kidney transplant recipients with atypical HUS","volume":"4","author":"Cheung","year":"2019","journal-title":"Kidney Int Rep"},{"issue":"17","key":"10.1053\/j.ackd.2020.01.002_bib33","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1080\/14767058.2018.1450381","article-title":"Adverse outcomes in obstetric-atypical haemolytic uraemic syndrome: a case series analysis","volume":"32","author":"Kozlovskaya","year":"2019","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"5","key":"10.1053\/j.ackd.2020.01.002_bib34","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.ekir.2018.12.014","article-title":"Pregnancy in a kidney transplant woman under treatment with eculizumab for atypical hemolytic uremic syndrome: is it safe?","volume":"4","author":"Duval","year":"2019","journal-title":"Kidney Int Rep"},{"issue":"1","key":"10.1053\/j.ackd.2020.01.002_bib35","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/AOG.0000000000003554","article-title":"Pregnancy-associated atypical hemolytic uremic syndrome: a systematic review","volume":"135","author":"Gupta","year":"2020","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1053\/j.ackd.2020.01.002_bib36","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12882-019-1469-9","article-title":"Reduced membrane attack\u00a0complex formation in umbilical cord blood during Eculizumab\u00a0treatment of the mother: a case report","volume":"20","author":"Nagarajah","year":"2019","journal-title":"BMC Nephrol"},{"issue":"1","key":"10.1053\/j.ackd.2020.01.002_bib37","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s40620-018-0517-z","article-title":"Eculizumab in pregnancy: a narrative overview","volume":"32","author":"Sarno","year":"2019","journal-title":"J Nephrol"},{"issue":"12","key":"10.1053\/j.ackd.2020.01.002_bib38","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1007\/s00467-019-04341-4","article-title":"Is eculizumab indicated in patients with atypical hemolytic uremic syndrome already on prolonged dialysis? A case report and review of the literature","volume":"34","author":"Haskin","year":"2019","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"10.1053\/j.ackd.2020.01.002_bib39","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1182\/blood-2014-02-553131","article-title":"Thrombotic thrombocytopenic purpura and pregnancy: presentation, management, and subsequent pregnancy outcomes","volume":"124","author":"Scully","year":"2014","journal-title":"Blood"},{"issue":"8","key":"10.1053\/j.ackd.2020.01.002_bib40","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1111\/j.1537-2995.2004.03422.x","article-title":"Pregnancy outcomes after recovery from thrombotic thrombocytopenic purpura-hemolytic uremic syndrome","volume":"44","author":"Vesely","year":"2004","journal-title":"Transfusion"},{"issue":"9","key":"10.1053\/j.ackd.2020.01.002_bib41","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1182\/blood.V98.9.2730","article-title":"Changes in health and disease of the metalloprotease that cleaves von Willebrand factor","volume":"98","author":"Mannucci","year":"2001","journal-title":"Blood"},{"key":"10.1053\/j.ackd.2020.01.002_bib42","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/nrneph.2012.195","article-title":"STEC-HUS, atypical HUS and TTP are all diseases of complement activation","volume":"8","author":"Noris","year":"2012","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"10.1053\/j.ackd.2020.01.002_bib43","doi-asserted-by":"crossref","first-page":"e59372","DOI":"10.1371\/journal.pone.0059372","article-title":"Assembly and activation of alternative complement components on endothelial cell-anchored ultra-large von willebrand factor links complement and hemostasis-thrombosis","volume":"8","author":"Turner","year":"2013","journal-title":"PLoS One"},{"issue":"13","key":"10.1053\/j.ackd.2020.01.002_bib44","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1182\/blood.2019001040","article-title":"Synergistic effects of ADAMTS13 deficiency and complement activation in pathogenesis of thrombotic microangiopathy","volume":"134","author":"Zheng","year":"2019","journal-title":"Blood"},{"issue":"3","key":"10.1053\/j.ackd.2020.01.002_bib45","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1182\/blood-2014-01-514752","article-title":"Current issues in chronic graft-versus-host disease","volume":"124","author":"Soci\u00e9","year":"2014","journal-title":"Blood"},{"issue":"10","key":"10.1053\/j.ackd.2020.01.002_bib46","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1111\/jth.12369","article-title":"Complement activation and mortality during an acute episode of thrombotic thrombocytopenic purpura","volume":"11","author":"Wu","year":"2013","journal-title":"J Thromb Haemost"},{"issue":"5","key":"10.1053\/j.ackd.2020.01.002_bib47","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1538-7836.2012.04674.x","article-title":"Complement activation in thrombotic thrombocytopenic purpura","volume":"10","author":"R\u00e9ti","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"3","key":"10.1053\/j.ackd.2020.01.002_bib48","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1160\/TH04-07-0450","article-title":"Complement activation: the missing link between ADAMTS-13 deficiency and microvascular thrombosis of thrombotic microangiopathies","volume":"93","author":"Ruiz-Torres","year":"2005","journal-title":"Thromb Haemost"},{"issue":"6","key":"10.1053\/j.ackd.2020.01.002_bib49","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1111\/bjh.12707","article-title":"Complement and cytokine response in acute thrombotic thrombocytopenic purpura","volume":"164","author":"Westwood","year":"2014","journal-title":"Br J Haematol"},{"issue":"12","key":"10.1053\/j.ackd.2020.01.002_bib50","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.2215\/CJN.13121211","article-title":"Obstetric nephrology: AKI and thrombotic microangiopathies in pregnancy","volume":"7","author":"Fakhouri","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.ackd.2020.01.002_bib51","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1600-0897.2005.00362.x","article-title":"Preeclampsia: the death of goliath","volume":"55","author":"Feinberg","year":"2006","journal-title":"Am J Reprod Immunol"},{"issue":"2","key":"10.1053\/j.ackd.2020.01.002_bib52","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1084\/jem.200116116","article-title":"Complement C3 activation is required for antiphospholipid antibody-induced fetal loss","volume":"195","author":"Michael Holers","year":"2002","journal-title":"J Exp Med"},{"key":"10.1053\/j.ackd.2020.01.002_bib53","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1161\/hy02t2.102904","article-title":"Discovery of a spontaneous genetic mouse model of preeclampsia","volume":"39","author":"Davisson","year":"2002","journal-title":"Hypertension"},{"issue":"3","key":"10.1053\/j.ackd.2020.01.002_bib54","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.4049\/jimmunol.1402220","article-title":"Prevention of defective placentation and pregnancy loss by blocking innate immune pathways in a syngeneic model of placental insufficiency","volume":"195","author":"Gelber","year":"2015","journal-title":"J Immunol"},{"issue":"6","key":"10.1053\/j.ackd.2020.01.002_bib55","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1161\/HYPERTENSIONAHA.113.01420","article-title":"Urinary excretion of C5b-9 in severe preeclampsia tipping the balance of complement activation in pregnancy","volume":"62","author":"Burwick","year":"2013","journal-title":"Hypertension"},{"issue":"1","key":"10.1053\/j.ackd.2020.01.002_bib56","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/AOG.0b013e3181fc3afa","article-title":"Early elevations of the complement activation fragment C3a and adverse pregnancy outcomes","volume":"117","author":"Lynch","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1053\/j.ackd.2020.01.002_bib57","doi-asserted-by":"crossref","first-page":"589","DOI":"10.3389\/fimmu.2017.00589","article-title":"Analysis of complement C3 gene reveals susceptibility to severe Preeclampsia","volume":"8","author":"Lokki","year":"2017","journal-title":"Front Immunol"},{"issue":"4","key":"10.1053\/j.ackd.2020.01.002_bib58","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/path.2893","article-title":"Classical complement activation as a footprint for murine and human antiphospholipid antibody-induced fetal loss","volume":"225","author":"Cohen","year":"2011","journal-title":"J Pathol"},{"issue":"5","key":"10.1053\/j.ackd.2020.01.002_bib59","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1161\/HYPERTENSIONAHA.112.194324","article-title":"Preeclampsia is characterized by placental complement dysregulation","volume":"60","author":"Buurma","year":"2012","journal-title":"Hypertension"},{"issue":"4","key":"10.1053\/j.ackd.2020.01.002_bib60","doi-asserted-by":"crossref","first-page":"385.e1","DOI":"10.1016\/j.ajog.2007.10.793","article-title":"Alternative complement pathway activation fragment Bb in early pregnancy as a predictor of preeclampsia","volume":"198","author":"Lynch","year":"2008","journal-title":"Am J Obstet Gynecol"},{"issue":"11","key":"10.1053\/j.ackd.2020.01.002_bib61","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.3109\/14767058.2012.694923","article-title":"The genetics of the alternative pathway of complement in the pathogenesis of HELLP syndrome","volume":"25","author":"Crovetto","year":"2012","journal-title":"J Matern Neonatal Med"},{"issue":"3","key":"10.1053\/j.ackd.2020.01.002_bib62","doi-asserted-by":"crossref","first-page":"e1001013","DOI":"10.1371\/journal.pmed.1001013","article-title":"Mutations in complement regulatory proteins predispose to preeclampsia: a genetic analysis of the PROMISSE cohort","volume":"8","author":"Salmon","year":"2011","journal-title":"Plos Med"},{"issue":"12","key":"10.1053\/j.ackd.2020.01.002_bib63","doi-asserted-by":"crossref","first-page":"4542","DOI":"10.1182\/blood-2008-03-144691","article-title":"Factor H, membrane cofactor protein, and factor I mutations in patients with hemolysis, elevated liver enzymes, and low platelet count syndrome","volume":"112","author":"Fakhouri","year":"2008","journal-title":"Blood"},{"issue":"6","key":"10.1053\/j.ackd.2020.01.002_bib64","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1172\/jci.insight.99128","article-title":"Germline mutations in the alternative pathway of complement predispose to HELLP syndrome","volume":"3","author":"Vaught","year":"2018","journal-title":"JCI insight"},{"issue":"5","key":"10.1053\/j.ackd.2020.01.002_bib65","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.exphem.2016.01.005","article-title":"Direct evidence of complement activation in HELLP syndrome: a link to atypical hemolytic uremic syndrome","volume":"44","author":"Vaught","year":"2016","journal-title":"Exp Hematol"},{"issue":"1","key":"10.1053\/j.ackd.2020.01.002_bib66","doi-asserted-by":"crossref","first-page":"485","DOI":"10.4049\/jimmunol.174.1.485","article-title":"TNF-\u03b1 is a critical effector and a target for therapy in antiphospholipid antibody-induced pregnancy loss","volume":"174","author":"Berman","year":"2005","journal-title":"J Immunol"},{"issue":"11","key":"10.1053\/j.ackd.2020.01.002_bib67","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1172\/JCI200318817","article-title":"Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome","volume":"112","author":"Girardi","year":"2003","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1053\/j.ackd.2020.01.002_bib68","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/ki.2010.393","article-title":"Targeted inhibition of complement activation prevents features of preeclampsia in mice","volume":"79","author":"Qing","year":"2011","journal-title":"Kidney Int"},{"issue":"4","key":"10.1053\/j.ackd.2020.01.002_bib69","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1136\/annrheumdis-2017-212224","article-title":"Complement activation predicts adverse pregnancy outcome in patients with systemic lupus erythematosus and\/or antiphospholipid antibodies","volume":"77","author":"Kim","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1053\/j.ackd.2020.01.002_bib71","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1002\/art.40508","article-title":"Pregnancy outcomes after exposure to certolizumab pegol: updated results from a pharmacovigilance safety database","volume":"70","author":"Clowse","year":"2018","journal-title":"Arthritis Rheumatol"},{"issue":"11","key":"10.1053\/j.ackd.2020.01.002_bib72","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/nm.2538","article-title":"Atherosclerosis: current pathogenesis and therapeutic options","volume":"17","author":"Weber","year":"2011","journal-title":"Nat Med"},{"issue":"9","key":"10.1053\/j.ackd.2020.01.002_bib73","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/ni.1923","article-title":"Complement: a key system for immune surveillance and homeostasis","volume":"11","author":"Ricklin","year":"2010","journal-title":"Nat Immunol"},{"issue":"1","key":"10.1053\/j.ackd.2020.01.002_bib74","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1073\/pnas.0603420103","article-title":"Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome","volume":"104","author":"Goicoechea de Jorge","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"10.1053\/j.ackd.2020.01.002_bib75","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1093\/ndt\/gfq160","article-title":"Myocardial infarction is a complication of factor H-associated atypical HUS","volume":"25","author":"Sall\u00e9e","year":"2010","journal-title":"Nephrol Dial Transpl"},{"issue":"10","key":"10.1053\/j.ackd.2020.01.002_bib76","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1371\/journal.pmed.0030431","article-title":"Atypical haemolytic uraemic syndrome associated with a hybrid complement gene","volume":"3","author":"Venables","year":"2006","journal-title":"Plos Med"},{"issue":"18","key":"10.1053\/j.ackd.2020.01.002_bib77","doi-asserted-by":"crossref","first-page":"4182","DOI":"10.1182\/blood-2011-10-383281","article-title":"A prevalent C3 mutation in aHUS patients causes a direct C3 convertase gain of function","volume":"119","author":"Roumenina","year":"2012","journal-title":"Blood"},{"key":"10.1053\/j.ackd.2020.01.002_bib78","article-title":"Atypical hemolytic uremic syndrome presenting as acute heart failure\u2014a rare presentation: diagnosis supported by skin biopsy","volume":"7","author":"Kichloo","year":"2019","journal-title":"J Investig Med High Impact Case Rep"},{"issue":"1","key":"10.1053\/j.ackd.2020.01.002_bib79","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1186\/1752-1947-8-307","article-title":"Postpartum thrombotic microangiopathy revealed as atypical hemolytic uremic syndrome successfully treated with eculizumab: a case report","volume":"8","author":"Kourouklaris","year":"2014","journal-title":"J Med Case Rep"}],"container-title":["Advances in Chronic Kidney Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1548559520300021?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1548559520300021?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T07:01:54Z","timestamp":1761548514000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1548559520300021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":78,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S1548559520300021"],"URL":"https:\/\/doi.org\/10.1053\/j.ackd.2020.01.002","relation":{},"ISSN":["1548-5595"],"issn-type":[{"value":"1548-5595","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complement-Mediated Disorders in Pregnancy","name":"articletitle","label":"Article Title"},{"value":"Advances in Chronic Kidney Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ackd.2020.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the National Kidney Foundation, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}